Aurinia Pharmaceuticals Inc. (AUPH) |
| 14.99 -0.29 (-1.9%) 01-13 16:00 |
| Open: | 15.23 |
| High: | 15.28 |
| Low: | 14.75 |
| Volume: | 1,097,833 |
| Market Cap: | 1,976(M) |
| PE Ratio: | 26.77 |
| Exchange: | NASDAQ Global Market |
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 16.54 |
| Resistance 1: | 15.86 |
| Pivot price: | 15.70 |
| Support 1: | 14.75 |
| Support 2: | 12.27 |
| 52w High: | 16.54 |
| 52w Low: | 6.55 |
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.
Financials
| EPS | 0.560 |
| Book Value | 2.770 |
| PEG Ratio | 0.00 |
| Gross Profit | 1.616 |
| Profit Margin (%) | 29.28 |
| Operating Margin (%) | 40.49 |
| Return on Assets (ttm) | 9.4 |
| Return on Equity (ttm) | 20.6 |
Company news
Sun, 11 Jan 2026
With 54% institutional ownership, Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) is a favorite amongst the big guns - Yahoo Finance
Tue, 06 Jan 2026
Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: Riding the Biotech Wave with 8.93% Potential Upside - DirectorsTalk Interviews
Tue, 30 Dec 2025
Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: A Biotech Contender with a 4.89% Upside - DirectorsTalk Interviews
Fri, 26 Dec 2025
Is Aurinia Pharmaceuticals (AUPH) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Thu, 25 Dec 2025
Aurinia Pharmaceuticals (NASDAQ:AUPH) rises 3.1% this week, taking three-year gains to 292% - simplywall.st
Tue, 16 Dec 2025
Aurinia Pharmaceuticals: Silencing Doubters, But Competition Looms (NASDAQ:AUPH) - Seeking Alpha
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
